Cargando…

Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson's Disease: A Cross-Sectional Study

AIMS: Polypharmacy is well known to affect cognitive function in community-dwelling older adults. However, the effect of polypharmacy on cognitive function in patients with newly diagnosed Parkinson's disease remains unknown. Here, we evaluated the association between polypharmacy and cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishii, Nobuyuki, Mochizuki, Hitoshi, Sakai, Katsuya, Ogawa, Go, Shiomi, Kazutaka, Nakazato, Masamitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787424/ https://www.ncbi.nlm.nih.gov/pubmed/31608098 http://dx.doi.org/10.1159/000502351

Ejemplares similares

Clinical features and electrocardiogram parameters in Parkinson’s disease
por: Mochizuki, Hitoshi, et al.
Publicado: (2017)

Reversible Parkinsonism Due to Diabetic Uremic Syndrome
por: Ishii, Nobuyuki, et al.
Publicado: (2020)

Severe Orthostatic Hypotension due to Unilateral Carotid Artery Dissection
por: Ishii, Nobuyuki, et al.
Publicado: (2014)

Clinical Symptoms, Neurological Signs, and Electrophysiological Findings in Surviving Residents with Probable Arsenic Exposure in Toroku, Japan
por: Ishii, Nobuyuki, et al.
Publicado: (2018)

A Case of Nivolumab-Induced Severe Mononeuropathy Multiplex and Rhabdomyolysis
por: Sakai, Katsuya, et al.
Publicado: (2017)

Body mass index and severity of parkinsonism in multiple system atrophy
por: Suzuki, Ai, et al.
Publicado: (2017)

(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging evaluation of chorea
por: Ishii, Nobuyuki, et al.
Publicado: (2018)

A Japanese Case of CADASIL with a Rare Mutation in Exon 24 of the NOTCH3 Gene
por: Ebihara, Yuka, et al.
Publicado: (2018)

Optic Neuropathy with Features Suggestive of Optic Neuritis in Cerebrotendinous Xanthomatosis
por: Miyamoto, Miyuki, et al.
Publicado: (2019)

A Sporadic Case of Charcot-Marie-Tooth Disease Type 2 with Left Vocal Fold Palsy due to Mitofusin 2 Mutation
por: Kanemaru, Kazuki, et al.
Publicado: (2019)

Human liver‐expressed antimicrobial peptide 2 elevation in the cerebrospinal fluid in bacterial meningitis
por: Sakai, Katsuya, et al.
Publicado: (2021)

Detailed Analysis of Neurological Symptoms and Sensory Disturbances Due to Chronic Arsenic Exposure in Toroku, Japan
por: Sugiyama, Takashi, et al.
Publicado: (2021)

Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
por: Pan, Chenxi, et al.
Publicado: (2021)

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2019)

A rare case of concomitant Lambert–Eaton myasthenic syndrome and syndrome of inappropriate antidiuretic hormone secretion in a patient with small cell lung carcinoma
por: Oda, Yasuharu, et al.
Publicado: (2023)

Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study
por: Sumbul-Sekerci, Betul, et al.
Publicado: (2023)

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
por: Nombela, Cristina, et al.
Publicado: (2014)

Progression of Cognitive Decline in Parkinson’s Disease
por: Roheger, Mandy, et al.
Publicado: (2018)

Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Polypharmacy-Induced Long QT Syndrome in a Patient With Newly Diagnosed Acute Myeloid Leukaemia: A Case Report
por: Khan, Zahid
Publicado: (2023)

Fractal analysis of (11)C-methionine PET in patients with newly diagnosed glioma
por: Maeda, Yukito, et al.
Publicado: (2021)

Predictors of cognitive impairment in newly diagnosed Parkinson’s disease with normal cognition at baseline: A 5-year cohort study
por: Chen, Jing, et al.
Publicado: (2023)

Pharmacological signatures of the reduced incidence and the progression of cognitive decline in ageing populations suggest the protective role of beneficial polypharmacy
por: Mayburd, Anatoly L., et al.
Publicado: (2019)

Quantitative EEG and Cognitive Decline in Parkinson's Disease
por: Cozac, Vitalii V., et al.
Publicado: (2016)

Cognitive decline in Parkinson’s disease: the complex picture
por: Biundo, Roberta, et al.
Publicado: (2016)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

Initial Medication in Patients of Newly Diagnosed Parkinson’s Disease in Taiwan
por: Guo, Yi-Jen, et al.
Publicado: (2014)

Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson’s Disease
por: Wang, Juan, et al.
Publicado: (2016)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Alternating flexed-extended posturing in progressive supranuclear palsy
por: Ishii, Nobuyuki, et al.
Publicado: (2019)

Predicting Cognitive Decline and Dementia with the Newly Normed SKT Short Cognitive Performance Test
por: Stemmler, Mark, et al.
Publicado: (2019)

Anorectal Manometric Dysfunctions in Newly Diagnosed, Early-Stage Parkinson's Disease
por: Sung, Hye Young, et al.
Publicado: (2012)

Development and validation of prognostic survival models in newly diagnosed Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2017)

Assessment of Atrial Conduction Times in Patients with Newly Diagnosed Parkinson's Disease
por: Çanga, Yiğit, et al.
Publicado: (2018)

Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease
por: Wen, Ming-Ching, et al.
Publicado: (2017)

Quality of Life in Newly Diagnosed Patients With Parkin-Related Parkinson's Disease
por: Zhou, Xin-Yue, et al.
Publicado: (2020)

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
por: Hanganu, Alexandru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_40mcb6p4f92nt3kvdomdkt7c27